Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dapagliflozin: A Review in Type 2 Diabetes
Sohita Dhillon
Drugs (2019) Vol. 79, Iss. 10, pp. 1135-1146
Open Access | Times Cited: 165

Showing 1-25 of 165 citing articles:

Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: Targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways
Hany H. Arab, Muhammad Y. Al‐Shorbagy, Muhammed A. Saad
Chemico-Biological Interactions (2021) Vol. 335, pp. 109368-109368
Closed Access | Times Cited: 117
The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
Bo Xu, Shaoqian Li, Bo-Kyeong Kang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 113
Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Dongrong Yang, Meng‐Yan Wang, Chenglin Zhang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 32
Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
Liuran Li, Qinghua Li, Wenbin Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 81
Multi-Spectroscopic, thermodynamic and molecular dynamic simulation studies for investigation of interaction of dapagliflozin with bovine serum albumin
Mohamed A. Abdelaziz, Moataz A. Shaldam, Ramadan A. El-Domany, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2021) Vol. 264, pp. 120298-120298
Closed Access | Times Cited: 58
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study
William V. Tamborlane, Lori M. Laffel, Naim Shehadeh, et al.
The Lancet Diabetes & Endocrinology (2022) Vol. 10, Iss. 5, pp. 341-350
Open Access | Times Cited: 57
Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities
Agnieszka Przezak, Weronika Bielka, Andrzej Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6500-6500
Open Access | Times Cited: 41
SGLT2 Inhibitors as Potential Anticancer Agents
Debasish Basak, David Gamez, Subrata Deb
Biomedicines (2023) Vol. 11, Iss. 7, pp. 1867-1867
Open Access | Times Cited: 37
Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2
Qingqing Wu, Qi Yao, Tongtong Hu, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 12, pp. 101334-101334
Open Access | Times Cited: 35
Chemical synthesis of oligosaccharides and their application in new drug research
Zhimin Lv, Hongyu Liu, Huifang Hao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115164-115164
Open Access | Times Cited: 23
SGLT2 inhibitors: Beyond glycemic control
Irtiza Hasan, Tasnuva Rashid, Vishal Jaikaransingh, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 35, pp. 100335-100335
Open Access | Times Cited: 14
Alzheimer’s Disease as Type 3 Diabetes: Understanding the Link and Implications
Mateusz Kciuk, Weronika Kruczkowska, Julia Gałęziewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11955-11955
Open Access | Times Cited: 11
Dapagliflozin prevents kidney podocytes pyroptosis via miR-155-5p/HO-1/NLRP3 axis modulation
Zhen-wang Zhang, Ming-Qiu Tang, Wu Liu, et al.
International Immunopharmacology (2024) Vol. 131, pp. 111785-111785
Closed Access | Times Cited: 7
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy
Hongtu Hu, Weiwei Li, Yiqun Hao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101690-101690
Open Access | Times Cited: 6
Dapagliflozin: A Review in Type 1 Diabetes
Julia Paik, Hannah A. Blair
Drugs (2019) Vol. 79, Iss. 17, pp. 1877-1884
Open Access | Times Cited: 46
SGLT2 is not expressed in pancreatic α- and β-cells, and its inhibition does not directly affect glucagon and insulin secretion in rodents and humans
Heeyoung Chae, Robert Augustin, Eva Gatineau, et al.
Molecular Metabolism (2020) Vol. 42, pp. 101071-101071
Open Access | Times Cited: 39
Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
Collin Vandemark, Jimmy Nguyen, Zhi‐Qing Zhao
Molecules (2023) Vol. 28, Iss. 3, pp. 1369-1369
Open Access | Times Cited: 15
Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney
Yan Yuan, Mengyao Sun, Zijie Jin, et al.
European Journal of Pharmacology (2023) Vol. 943, pp. 175560-175560
Closed Access | Times Cited: 13
Dapagliflozin alleviates renal fibrosis in a mouse model of adenine-induced renal injury by inhibiting TGF-β1/MAPK mediated mitochondrial damage
Jianhua Zeng, Hao Huang, Yan Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Cardiovascular Diseases: Therapeutic Potential of SGLT-2 Inhibitors
Weronika Frąk, Joanna Hajdys, Ewa Radzioch, et al.
Biomedicines (2023) Vol. 11, Iss. 7, pp. 2085-2085
Open Access | Times Cited: 13
SGLT2 inhibitors attenuate endothelial to mesenchymal transition and cardiac fibroblast activation
Kevin Schmidt, Arne Schmidt, Sonja Groß, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Based on network pharmacology-molecular docking and experimental exploration, the preventive and therapeutic effects of dapagliflozin on gouty arthritis in rats were investigated
Ye Tao, Jingfang Du, Pian Li, et al.
Research Square (Research Square) (2025)
Closed Access
Protective effect of dapagliflozin on lipopolysaccharide-induced acute lung injury via the SIRT-1/PGC-1α pathway
Mehtap Savran, Suleyman Emre Akin, Hasan Ekrem Çamaş, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Antidiabetic drugs based on sodium-glucose cotransporter 2 inhibitors
Youhong Niu, Xin‐Shan Ye
Elsevier eBooks (2025), pp. 55-70
Closed Access
LATS1-modulated ZBTB20 perturbing cartilage matrix homeostasis contributes to early-stage osteoarthritis
Xue Hao, Jing Zhao, Liyuan Jia, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top